Skip to main content

Post-IPO Equity Biopharma Companies

Explore 3 biopharma startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
3
Total Funding
$255.0M
Avg Funding
$85.0M
Cities
3

Export 3 Post-IPO Equity Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Waltham, United States
$100.0M
raised

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Los Altos, United States
$120.0M
raised

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

La Jolla, United States
$35.0M
raised

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Ready to Connect with Post-IPO Equity Biopharma Startups?

Get verified founder emails, funding details, and company data for 3 post-ipo equity biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

3 Recently Funded Biopharma Post-IPO Equity Startups (July 2026) | VCBacked